New Technology for Cervical Cancer Screenings

Guest Bio: Kim Stebbings, President of DySIS Medical

Kim Stebbings brings over 25 years of U.S. medical device sales, marketing and operational experience in multi-national and start-up companies. She spent 16 years with Boehringer Mannheim/Roche Diagnostics where she held multiple positions including P&L responsibility for a $100 million diagnostics business. The balance of her career has been dedicated to leading start-up commercial organizations including BioStar, Inc., a diagnostics company sold to Thermo Electron (NYSE:TMO) and Medingo, Ltd, an Israeli insulin pump company acquired by Roche Holdings AG (ROG.VX). Kim was most recently President of GlycoMark, Inc. a diagnostics subsidiary of Toyota Tsusho America and has a B.S. degree in Biology from St. Lawrence University.